Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00769002 · ClinicalTrials.gov registry record · NA
PET-CT Scans in Healthy Volunteers After Flu Vaccination
A NA study, sponsored by Hackensack Meridian Health.
- Terminated
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT00769002: Clinical Trial NA study, sponsored by Hackensack Meridian Health.
NCT00769002 is a NA study that was terminated before completion, run by Hackensack Meridian Health. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00769002, a NA study, was terminated before completion, sponsored by Hackensack Meridian Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
This study is being done to learn how previous flu vaccination or previous infection with flu virus affects the immune response to vaccination.
Primary Outcome
Natural infection but not ipsilateral IM injection of FluShield, will prime the host for a specific activation of spleen and bilateral lymph nodes following a subsequent i.m injection of FluShield, as detected by PET-CT performed 4-7 days post- FluShield immunization.
Interventions
- PROCEDURE Blood Draws
- BIOLOGICAL FluShield
- BIOLOGICAL FluShield - same arm
- BIOLOGICAL FluShield - opposite arm
- PROCEDURE FDG PET-CT Scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2008-09 |
| Est. Completion | 2011-08 |
| Phase | NA |
Why NCT00769002 stopped before completion
NCT00769002 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 5 interventions - of which Blood Draws is the first listed.
NCT00769002 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00769002 about?
NCT00769002 is a clinical study titled "PET-CT Scans in Healthy Volunteers After Flu Vaccination". This study is being done to learn how previous flu vaccination or previous infection with flu virus affects the immune response to vaccination.
What is the current status of trial NCT00769002?
This trial is currently terminated. It is a NA study. The enrollment target is 18 participants. The study started on 2008-09. Estimated completion is 2011-08.
What interventions are being tested in trial NCT00769002?
The interventions under investigation include: Blood Draws (PROCEDURE), FluShield (BIOLOGICAL), FluShield - same arm (BIOLOGICAL), FluShield - opposite arm (BIOLOGICAL), FDG PET-CT Scan (PROCEDURE).
Who is sponsoring clinical trial NCT00769002?
This trial is sponsored by Hackensack Meridian Health, which has 90 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00769002's enrollment target sits among peer trials
18 1863rd of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia